Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

NCT: NCT06075901 · ENROLLING_BY_INVITATION

NCT IDNCT06075901
StatusENROLLING_BY_INVITATION
Start Date2025-08-01
Completion2027-07
SponsorPaulista University (OTHER)
First posted
Last updated

Brief Summary

Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

Frequently Asked Questions

What is Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.?

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction. is a clinical trial registered under NCT06075901. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06075901?

The current status of NCT06075901 (Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.) is: ENROLLING_BY_INVITATION.

When did Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction. start?

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction. started on 2025-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑